AIM2: Adequate Selection of Patients for Thyroid Biopsy: Evaluation of a Shared Decision Making Conversation Aid
University of Florida
University of Florida
Sanofi
Sanofi
Memorial Sloan Kettering Cancer Center
Sichuan Enray Pharmaceutical Sciences Company
Medical College of Wisconsin
Dana-Farber Cancer Institute
Stanford University
Hoffmann-La Roche
Mayo Clinic
Alume Biosciences, Inc.
National Cancer Institute (NCI)
Alliance for Clinical Trials in Oncology
Vanderbilt-Ingram Cancer Center
University of Florida
Academic and Community Cancer Research United
Virginia Commonwealth University
Sanofi
University of Wisconsin, Madison
Dana-Farber Cancer Institute
National Cancer Institute (NCI)
University of Nebraska
Eisai Inc.
Memorial Sloan Kettering Cancer Center
Eisai Inc.
Dana-Farber Cancer Institute
Stanford University
Exelixis
Emory University
Eisai Inc.
Medstar Health Research Institute
Eisai Inc.
National Cancer Institute (NCI)
University of Wisconsin, Madison
Pfizer
Medical University of South Carolina
National Cancer Institute (NCI)
Amgen
Bayer
Memorial Sloan Kettering Cancer Center
National Institutes of Health Clinical Center (CC)
Sanofi
University of Chicago
Seoul National University Hospital
Massachusetts General Hospital
University of Washington
Memorial Sloan Kettering Cancer Center
Novartis
Massachusetts General Hospital
National Cancer Institute (NCI)